Medicine and public health are evidence-based fields, yet many of our programs do not receive close scrutiny as to whether they are meeting their objectives. 1 This observation applies to both new programs and older programs. To be sure, our accountants can and will tell us when billings fall below expenses and when charging market-level fees is insufficient to meet payroll. Whether our programs are achieving clinical or community health goals may not be assessed with equal precision, however.
Innovation abounds in primary care and community health practice. New programs are launched annually in many communities. Local foundations support nonprofit groups heroically struggling with intransigent social problems. Primary care clinics occasionally experiment with practice changes in an effort to modify lifestyle, increase appropriate use of prevention services, or improve control over chronic diseases. Appropriate metrics for measuring the success of these innovations are readily available, yet staff members are often left wondering at the end of the year about how successful their efforts really were.
The same problem applies to older programs. Programs that began a few years ago may be dwindling, with funders unsure as to when and whether they should begin to phase these programs out. Other programs are financially successful but may not be making much real difference in the health of the targeted populations. Quantitative impact evaluation studies would provide helpful guidance to these organizations and their sponsors.
Unfortunately, the study designs most appropriate for these situations are not well understood. Although almost everyone has heard that the randomized experiment offers the gold standard in study design, few understand 2 important additional truths: (1) observational studies can provide useful and valid information if carefully conducted and cautiously interpreted, 2 and (2) the results of randomized studies can be misleading. 3 Most of us will acknowledge, however, that random assignment often is not practical in field situations.
Nonrandomized impact evaluation studies are not a perfect solution but, carefully executed, can offer useful evidence in support of a program. Several nonrandomized ("observational") designs have been described for use in the health care field. 4 Although observational designs are common in epidemiology, they are not fully accepted in biostatistics, experimental psychology, or the mainstream of clinical research, which focuses on drug trials. Even though epidemiologists use observational designs routinely to produce valid conclusions, inadvertent misuse of such designs is possible. Although the findings derived from nonrandom impact evaluations are in some ways "softer" than those from randomized experiments, performing observational studies well is more challenging than conducting a true experiment, because the interpretations might require more caveats and the statistical methods are more complex.
Readers of this journal might benefit from some suggestions about how to undertake observational studies in field settings. These are presented as 3 errors and 3 tips. Keeping these simple rules in mind can make the difference between producing a publishable impact evaluation and conducting one that does not generate useful results.
Error 1: Embarking on an Underpowered Study
Studying a small number of patients is easier but shortsighted. If no significant differences are found between groups, the most obvious explanation will be lack of statistical power. No one whose ox is gored by your data should let this point go unmentioned. The net impact of the study is likely to be nil. User-friendly power calculators are readily available online and should be used to estimate the number of cases needed to detect an impact on your dependent variable. As a general rule, more cases are more convincing. Pilot studies can be done in a single site, rather than multiple locations, but even pilot studies should have an adequate sample. Because nonrandom studies may require use of regression methods to adjust for group differences, asking for a minimum of 100 cases per group would not be an unreasonable guideline.
Error 2: Not Using a Comparison Group
Comparison groups are readily available. If a community health program is being assessed, data can be obtained from persons not reached by the project. These might be in another community or perhaps another neighborhood. When investigators are evaluating a clinical project, patients from a similar practice can provide an excellent comparison. Having 2 comparison groups is better than having 1, because the findings of the 2 comparisons can be mutually reinforcing, thus providing reassurance that a single comparison group cannot offer. 5
Error 3: Not Adjusting for Group Differences
The most widely recognized problem with observational studies is inadequate control of confounders. 3 Perhaps the simplest approach to solving this problem is to use a matched sample, thus eliminating group differences on the matching variables. This is easier said than done, because hundreds of cases might have to be searched to find a handful of matches. The net result might be a small sample, thus leading back to Error 1.
In the absence of a matched sample, dummy variable regression analysis or analysis of covariance can be used to adjust for group differences when the outcome variable is continuous. Results can still be biased, however, and the investigator should use appropriate caution in drawing conclusions.
When the outcome is discrete (such as "met standard" vs "did not meet standard"), multiple logistic regression is useful. Logistic methods are more forgiving than linear regression, because they allow for nonlinearities in the data. Health variables often are not related to each other in simple linear ways.
Tip 1: Examine Difference in Differences
Baseline scores can be subtracted from outcome scores to measure how much change occurred. For example, body mass index (BMI) at outcome minus baseline BMI equals the difference experienced by the individuals reached by a program. The same information can be obtained for the individuals in the comparison group to compute the difference obtained in that group. The mean difference for the intervention group minus the mean difference for the comparison group would be the "difference in the differences" (DID). A significance test is needed to determine whether the DID is larger than might have occurred by chance. For an illustration of this approach see Linden et al, 6 who evaluated the impact of a coaching program on 106 chronically ill employees by comparing their mean differences on several variables to those of 230 nonparticipants. The DID approach is logical and persuasive but can run into a problem of Error 3 (selection bias) when subjects are not randomly assigned to groups.
Tip 2: Be Prepared to Deal With Unequal Variances and Skewed Distributions
When analyzing observational data, a test for equality of variances may rule out a standard analysis of variance (ANOVA). The Kruskal-Wallis test for ranks is an appropriate, simple 2-group test, but if selection bias has resulted in significant differences in patient characteristics, multiple regression methods may be necessary. In this situation, using the rank score as the dependent variable might be helpful. For example, my colleagues and I 7 used the rank of standard costs instead of the dollar amount when assessing the impact of a retail medicine clinic. This was necessary because of unequal variances between the 2 groups.
Another approach is to break the distribution into "outliers" and "others" using an arbitrary cut point such as the 80th percentile. This allows multiple logistic regression analysis of the odds of being an outlier. Defining an outlier as being in the top 20% on the basis of costs has intuitive appeal, because most of the scholar-practitioners working in medicine have heard of the 80:20 rule: 20% of patients use 80 percent of the resources. A search on the term 80:20 rule yields more than 75 000 hits, demonstrating the ubiquity of the concept. An impact evaluation of online primary care visits provides an example of an outlier analysis. 8
Tip 3: Be Pragmatic About Selection of Metrics
New programs and changes in clinical practice have goals, and those goals include outcomes for the targeted individuals. Program outcomes are dependent variables. A brief literature search will reveal which dependent variables have been used previously as outcome measures for programs similar to the one being considered. Using these variables, which we might call standard metrics, will make results directly comparable with those reported in the literature. Innovators who invest a lot of committee time in developing new measures may find that they have done more harm than good and at great expense. Rapidly completed impact evaluations are more timely and therefore more useful than those year-long studies that fail to produce a report until well after most people have forgotten that the project was launched. Automatically using standard metrics will keep the evaluation moving along at a rapid pace. This recommendation, of course, assumes that the project leaders have perused the relevant literature before charging ahead with their innovations. Unfortunately, this is not always a safe assumption.
Conclusion
At times, practitioners in our field seem to divide naturally into 2 groups: innovators and skeptics. Innovators want to improve quality and efficiency. They have seen presentations about the future of public health and the future of primary care and are eager to join the ranks of the change-makers.
Quietly resisting the Innovators are the skeptics, whom we might label the Old Guard. The Old Guard has seen wave after wave of innovations in quality and efficiency, many of which have turned out to be faddish but glitzy packages that make money for consultants and bring promotions to Innovators but leave little in the way of lasting legacies except more digitized "paperwork" work for practitioners. They have work to do and perceive most innovations to be timewasters. After all, most apparently good ideas can be expected to generate unimpressive results. Publication bias is a big factor here: failed innovations are unlikely to appear in print. For every success story published, an unknown number of tests of the same innovation may have failed and died unreported. In addition, innovators are enthusiastic about their programs and may present the results in the best light possible. These 2 forms of bias conspire to create an exaggerated sense of the value of many innovations.
Both perspectives have merit. Consider lifestyle change programs as an example. Clinical experience has led many to conclude that people are unlikely to give up their unhealthy habits, regardless of the type of program we use to modify behavior. This jaded but realistic view is in conflict with the optimistic stance of care managers, lifestyle coaches, and others in this field. And why should they not be optimistic? A typical randomized trial of a behavioral change program will show some small but significant improvements in the group averages. Even though many individuals will fail, behavioral change programs can be expected to help others.
Observational impact evaluation studies can help find a middle ground between the Old Guard and the Innovators.
Innovative programs are less likely to be resisted if they are launched as pilot projects intended to test their merits in actual practice. Realistically, we might expect most pilot studies to be "unsuccessful," but learning what does not work is of great value. And learning what works for people of particular age, gender, ethnic, or educational levels will allow for careful targeting, tailoring, and control of program costs. Through trial and error, we can continually refine the elements of effective programs in primary care and community health.
